Trump Warns Pharma Firms of 5-8% Extra Tariffs Ahead of October Drug Pricing Deadline
- 04 October 2025
- 4 weeks ago
MSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in India
- 04 October 2025
- 4 weeks ago
AstraZeneca Pharma India gains CDSCO permission for Enhertu in HER2-positive solid tumours
- 04 October 2025
- 4 weeks ago
CDSCO panel nod to Bajaj Healthcare for Phase III clinical trials of insomnia drug Suvorexant
- 04 October 2025
- 4 weeks ago
CDSCO Flags MSD Pharma's Cancer Drug Trial Over Indian Representation, Control Arm
- 04 October 2025
- 4 weeks ago
Sresan Pharma's Coldrif Syrup Banned After 48.6% Toxic Diethylene Glycol Detected
- 04 October 2025
- 4 weeks ago
Not All Combipacks Are New Drugs: CDSCO Defines Approval Rules for Lyophilized Injections
- 01 October 2025
- 1 month ago
Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol
- 30 September 2025
- 1 month ago
Bombay HC Quashes Maharashtra FDA, CDSCO Stop-Production Orders Against 2 Pharma Firms
- 30 September 2025
- 1 month ago
Recent News
Himachal notifies Resident doctor policy 2025
- 02 November, 2025
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.









